(Q36560412)
Statements
1 reference
Randomized, double-blind, dose-ranging study of TAK-875, a novel GPR40 agonist, in Japanese patients with inadequately controlled type 2 diabetes (English)
1 reference
Kohei Kaku
1 reference
Takahiro Araki
1 reference
Ryoji Yoshinaka
1 reference
18 October 2012
1 reference
1 reference
245-250
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference